ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,585Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 1300

$484K Total Retail Price of All Prescriptions

Rank: 35 out of 1300

537 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 537 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

18% of this provider’s 537 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,970 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 500 471 1 1
HYDROCODONE-ACETAMINOPHEN 443 364 S3 2 5
LISINOPRIL 341 306 3 2
FUROSEMIDE 271 244 4 8
SIMVASTATIN 234 199 5 3
AMLODIPINE BESYLATE 207 181 6 6
WARFARIN SODIUM 201 184 7 9
METOPROLOL TARTRATE 197 155 8 11
METOPROLOL SUCCINATE 176 127 9 24
ZOLPIDEM TARTRATE 176 122 9 14
ALENDRONATE SODIUM 170 142 11 20
HYDROCHLOROTHIAZIDE 157 157 12 10
GABAPENTIN 146 136 13 15
LOSARTAN POTASSIUM 146 131 13 16
OMEPRAZOLE 138 84 15 4
FLUTICASONE PROPIONATE 132 129 16 30
CHLORTHALIDONE 132 126 16 151
METFORMIN HCL 118 113 18 7
ATENOLOL 115 111 19 12
POTASSIUM CHLORIDE 110 97 20 18
ATORVASTATIN CALCIUM 97 93 21 13
ENALAPRIL MALEATE 95 91 22 93
FLUOXETINE HCL 94 82 23 31
DIGOXIN 94 69 23 48
PRAVASTATIN SODIUM 88 67 25 23
ADVAIR DISKUS 87 68 26 41
SERTRALINE HCL 84 64 27 26
TRAZODONE HCL 83 70 28 34
OXYCODONE-ACETAMINOPHEN 81 57 S2 29 28
TAMSULOSIN HCL 79 55 30 25
PREDNISONE 76 65 31 40
KLOR-CON M10 73 72 32 144
DONEPEZIL HCL 71 71 33 32
KLOR-CON M20 66 43 34 60
CEPHALEXIN 66 58 34 89
ALLOPURINOL 64 63 36 29
LANTUS 64 55 36 43
CITALOPRAM HBR 62 50 38 19
PERMETHRIN 61 59 39 311
TRAMADOL HCL 59 49 40 17
AMITRIPTYLINE HCL 59 47 R 40 63
FENTANYL 57 28 S2 42 56
CARBIDOPA-LEVODOPA 56 56 43 68
OXYCODONE HCL 55 42 S2 44 35
LOVASTATIN 55 55 44 22
PANTOPRAZOLE SODIUM 55 51 44 36
OXYCODONE HCL-ACETAMINOPHEN 52 28 S2 47 83
VENTOLIN HFA 51 33 48 109
COMBIVENT 50 33 49 138
TERAZOSIN HCL 50 50 49 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.